GTCbio

Thomas Li, Senior Director of Technology Management and US Chief Technology Officer at Hoffmann - La Roche to give a presentation on “Oncology Biomarker Discovery Technologies of Today and Tomorrow” at GTCbio’s 3rd Oncology Biomarkers Conference on January 27-28, 2011 in San Diego,... - November 26, 2010

Jeremy Barton, VP of Oncology at Biogen Idec will be the keynote presenter on “Targeted Drug Delivery: How Far from the Bulls Eye?” at GTCbio’s Cancer Drugs Research & Development Conference on January 27-28, 2011 in San Diego, CA. Dr. Barton will address why the narrow therapeutic... - November 25, 2010

Andrew Crew, Director of Cancer Chemistry at OSI Pharmaceuticals will give a presentation on “Imidazo[1,5-a]pyrazines: Selective and Orally Efficacious mTORC1/2 Inhibitors” at the 5th Annual Protein Kinases in Drug Discovery conference to be held this year in Boston, MA on May 27-28, 2010 by GTCbio. - March 17, 2010

Katy Spink, Vice President of Operations for Geron, will give the Featured presentation at GTCbio’s 6th Stem Cell Research & Therapeutics Conference, May 27-28, 2010 in Boston, MA. - March 14, 2010

Barbara Wirostko, Senior Medical Director, Team Lead Ophthalmology, Pfizer will give a presentation at GTCbio’s 2nd Annual Ocular Disease Drug & Discovery Conference, May 27 – 28, 2010 in Boston, MA. - March 13, 2010

GTCbio’s 5th Annual Modern Drug Discovery & Development Conference (to be held October 14-16, 2009 in San Diego, CA) has an important focus on Stem Cell Discovery & Development. The Stem Cell track is to deliver information regarding cutting-edge developments in all areas of stem cell research. - August 21, 2009

GTCbio’s 5th Annual Modern Drug Discovery & Development Conference (held on October 14-16, 2009 in San Diego, CA) has placed a focus upon Translational Medicine with its individual Track. The Summit gives attendees from scientists to patients the opportunity to meet and discuss. - August 19, 2009

Amy Scott-Billman, Vice President of Global Regulatory Strategy for Immunotherapeutics at GlaxoSmithKline Biologicals, is to give a keynote presentation concerning regulatory considerations & challenges for immunotherapeutic/diagnostic co-development at GTCbio’s 5th Modern Drug Discovery & Development Summit, on October 14th-16th, 2009, in San Diego, CA. - July 31, 2009

The conference is in session from October 1-2, 2009 in Lisbon, Portugal with topics ranging from how to decrease the cost of drug discovery to translational research. - July 09, 2009

Alison Goss Eng, from the United States Department of Energy will be the featured speaker at GTCbio’s Inaugural Biofuels: Science and Innovation for Sustainable Development Conference on June 28-30, 2009 in San Francisco, California. Alison Goss Eng will deliver her featured address entitled “U.S.... - March 14, 2009

Dr. Susan Richards, Group VP of Clinical Laboratory Sciences at Genzyme is scheduled to give the keynote presentation at GTCbio’s 3rd annual Immunodiagnostics & Immunomonitoring Conference. - January 24, 2009

Thomas A. Waldmann, M.D., Chief of the Metabolism Branch at the NCI, NIH will give the keynote presentation at GTCbio’s at 3rd Annual Immunodiagnostics & Immunomonitoring Conference on April 23-24, 2009 in Chicago, IL. - January 08, 2009

Charles Peterfy, Chief Scientific Officer at Synarc will give the featured presentation at GTCbio’s 4th annual Imaging in Preclinical & Clinical Drug Development Conference on March 16-17, 2009 in San Francisco, CA. - January 02, 2009

Gregory A. Bonfiglio, Managing Partner at Proteus Venture Partners will give the featured presentation at GTCbio’s 5th Stem Cell Research & Therapeutics Conference on March 9-10, 2009 in Boston, MA. - December 31, 2008

Dr. De Yang, Senior Scientist of the Cellular Immunology Group at the National Cancer Institute of the National Institutes of Health will present at the 7th Cytokines & Inflammation Conference on January 29-30, 2009 in San Diego, CA. - December 12, 2008

GTCbio just announced its 2nd Annual Oncology Biomarkers Conference taking place on January 19-20, 2009 in Miami, Florida. The conference will take attendees through “The Life Cycle of a Cancer Biomarker”; examining the path from the identification of a candidate biomarker, development through... - November 19, 2008

Dr. Samir Hanash, Program Head at the Fred Hutchinson Cancer Research Center in Seattle, WA will give the keynote address on the discovery and development of biomarkers at the 2nd annual Oncology Biomarkers Conference on January 19-20 in Miami, Florida. Dr. Hanash will present on findings from studies... - November 19, 2008

GTCbio announced its Inaugural CNS Partnering & Deal-Making Summit being held on December 1-2, 2008 in Boston, MA. This event is one of the leading CNS disease partnering forums bringing together members of government, industry and academia to discuss the latest advancements in the field. Leaders... - November 07, 2008

Dr. Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono International in Geneva, Switzerland will present at the Plenary Keynote session at GTCbio’s 4th Modern Drug Discovery and Development Summit on October 15-17, 2008 at the Hilton La Jolla Torrey Pines in La Jolla, CA. Dr.... - August 23, 2008

Dr. Stanley Deresinski, Clinical Professor of Medicine-Med/Infectious Diseases at Stanford University in Palo Alto, CA will speak on “The Seemingly Never-ending Promise of Bacteriophage Therapy: Exploiting Smaller Fleas” at GTCbio’s Bugs & Drug Conf. on Sept. 22-23, 2008 at the... - August 21, 2008

Sharath Hegde, Vice President of Pharmacology at Theravance, Inc. in South San Francisco, CA will speak on “Telavancin: A Novel Lipoglycopeptide Gram-Positive Antibiotic” at GTCbio’s Bugs & Drug Conference on September 22-23, 2008 at the DoubleTree Club Hotel in San Diego, CA. Telavancin... - August 21, 2008

Dr. Rita Helfand, Associate Director of Epidemiologic Science at the National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention will speak on “Controlling Infectious Diseases: Progress and Challenges in Addressing Known and Unknown... - August 21, 2008

Dr. Barry Eisenstein, Senior Vice President of Scientific Affairs at Cubist Pharmaceuticals in Lexington, MA and Clinical Professor of Medicine, Harvard Medical School in Cambridge, MA gives the keynote address on getting congress to understand the need for antibiotic development. In contrast to the... - August 21, 2008

Dr. Ashraf Hanna, Vice President of Alliance Management and Portfolio Planning at Genentech in San Francisco, CA will present at the Plenary Keynote session at GTCbio’s 4th Modern Drug Discovery and Development Summit on October 15-17, 2008 in La Jolla, CA. Dr. Hanna will present on The Cost and... - August 09, 2008

GTCbio just announced the commencement of its inaugural conference on Global Clinical Trial Operations taking place on September 25-26, 2008 in San Diego, CA. Outsourcing to CROs has proven to be much more cost effective and less time consuming when conducting clinical trials. The steps to ensuring... - August 09, 2008

GTCbio just announced the 3rd edition of its Biomarker Series – the Biomarker Discovery Europe Conference - taking place on October 2-3, 2008 in Dublin, Ireland. Over the last several years, biomarkers have been an increasingly important and a heavily researched topic at all of the leading pharmaceutical... - August 09, 2008

GTCbio just announced its inaugural Bugs & Drugs conference – one of the leading forums to address unmet medical needs for problematic microbials - taking place on September 22-23, 2008 in San Diego, CA. Infections are becoming increasingly problematic due to the recent resistances to current... - August 09, 2008

GTCbio just announced the scheduling of its 4th annual Neurodegenerative Diseases Drug Discovery Conference on October 9-10, 2008 in Philadelphia, PA. Neurodegenerative diseases continue to play an enormous role in the growing public health problem, disrupting the quality of life of millions of people... - August 09, 2008

Dr. Robert J. Davie, Vice President & General Manager of Clinical Development Services - Europe at Covance will give a presentation entitled “The Service Provider Perspective: How are CROs Preparing for the Future of Clinical Outsourcing?” at GTCbio’s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA. - July 18, 2008

Brahm Goldstein Novo Nordisk speaking regarding a rational approach towards pediatric drug development in the pharmaceutical industry at GTCbio’s Global Clinical Trial Operations Conference on 9/25-26. - June 20, 2008

Charlene Dark, Dir. of Life Sciences at Clarkston Consulting will be present on expediting accuracy through electronic data capture at GTCbio’s Global Clinical Trial Operations Conference on Sept. 25-26 in San Diego. - June 20, 2008

Cosimo Spera from Decision View Co. will give a presentation entitled “Marrying Complex Mathematical Models with Highly Usable Software Solutions to Improve Trial Enrollment Performance” at GTCbio’s Global Clinical Trial Operations Conference. - June 20, 2008

Amrit Ray, Vice President of Bristol-Myers Squibb will give the keynote presentation at GTCbio’s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA. Dr. Ray will give a presentation entitled “The Next Generation of Pharmacovigilance - Clinical Trials and Drug Development in the New Era of Drug Safety. - June 18, 2008

Paul Watt, Vice President of Drug Discovery at Phylogica to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA. - June 13, 2008

Lino Gonzalez from Genentech to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA. - June 13, 2008

Kanji Takada, Group Leader of Experimental Therapeutics at Celgene to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA. - June 13, 2008

David Szymkowski, Senior Director of Biotherapeutics at Xencor will Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA - June 13, 2008

Dr. Keith James, Senior Vice President and Site Head of Pfizer La Jolla will present at the Plenary Keynote session at GTCbio’s 4th Modern Drug Discovery and Development Summit on October 15-17, 2008 at the Hilton La Jolla Torrey Pines in La Jolla, CA. Dr. James’ will speak on the challenges... - June 12, 2008

Dr. Y. Gloria Meng, Senior Scientist of Technology at Genentech will give a presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Meng will speak on electrochemiluminescence to detect surface proteins on live cells. - April 30, 2008

Dr. Matthew Olson, Principle Research Scientist at Johnson & Johnson will give a presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Olsen will present on “Coupling Label-free and Flouormetric Functional Assays... - April 18, 2008

Chris Austin, Director of the NIH Chemical Genomics Center to give Keynote Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA Dr. Christopher P. Austin, Director of the NIH Chemical Genomics Center will give the Keynote Presentation... - April 10, 2008

Dr. Hakim Djaballah, Director of High Throughput Screening Core Facility at the Memorial Sloan Kettering Cancer Center will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Djaballah will speak on successful applications... - April 03, 2008

John Cuozzo, Director of ELT Lead Discovery at GlaxoSmithKline to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA Dr. John W. Cuozzo, Director of ELT Lead Discovery at GlaxoSmithKline will present at GTCbio’s 3rd Assay... - April 03, 2008

Dr. Xi Chen, Assistant Professor in the Department of Chemistry at the University of California, Davis will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. - April 03, 2008

Dr. Taosheng Chen, Director of HTS, St. Jude Children's Research Hospital will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Chen will speak on a chemical biology approach to identify modulators of xenobiotic receptor... - April 03, 2008

Dr. Clay Scott, Associate Director of the Lead Generation Department at AstraZeneca will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Clay will speak on experiences in lead generation focusing on cellular dielectric... - April 03, 2008

Dr. Susan Taylor, Professor of Pharmacology at UCSD, will be giving the Featured Presentation at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA. - March 30, 2008

Dr. Karim Dabbagh the Director of Pharmacology at Hoffmann-La Roche will present at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA. - March 30, 2008

Dr. Berta Strulovici, Vice President of Basic Research MRL, and Automated Biotechnology Head at Merck & Co. will give Keynote Presentation at GTCbio’s 4th Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. - March 28, 2008

Dr. Robert Hertzberg, Vice President of Screening & Compound Profiling at GlaxoSmithKline will give the Keynote Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Hertzberg will present on “High Throughput Screening: A Technology That’s Easy to Love and Easy to Hate.” - March 28, 2008